tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Adnan Butt, 50 are a BUY (86.21%), 2 are a HOLD (3.45%), 6 are a SELL (10.34%).
Analyst Adnan Butt, carries an average stock price target met ratio of 79.26% that have a potential upside of 88.81% achieved within 512 days. Previously, Adnan Butt worked at GUGGENHEIM, RBC.
Adnan Butt’s has documented 103 price targets and ratings displayed on 10 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on REGN, Regeneron Pharmaceuticals at 22-Feb-2019.
Analyst best performing recommendations are on ITCI (INTRACELLULAR TH).
The best stock recommendation documented was for ITCI (INTRACELLULAR TH) at 9/16/2015. The price target of $42 was fulfilled within 9 days with a profit of $6.79 (13.92%) receiving and performance score of 15.46.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 26-Nov-2019
$85
$0.1 (0.12%)
6 years 3 months 2 days ago
(26-Nov-2019)
0/2 (0%)
$1.12 (1.34%)
Hold Since 25-Nov-2019
$85
$0.1 (0.12%)
$100
6 years 3 months 3 days ago
(25-Nov-2019)
0/4 (0%)
$1.25 (1.49%)
Buy Since 30-Nov-2017
$68
$-16.9 (-19.91%)
$68
6 years 3 months 3 days ago
(25-Nov-2019)
3/5 (60%)
$-15.75 (-18.81%)
294
Buy Since 19-Apr-2017
$60
$-24.9 (-29.33%)
$55
6 years 3 months 28 days ago
(31-Oct-2019)
5/5 (100%)
$7.51 (14.31%)
205
Buy Since 28-Aug-2015
6 years 4 months 18 days ago
(10-Oct-2019)
7/7 (100%)
$10.17 (19.62%)
287
What Year was the first public recommendation made by Adnan Butt?
